Dr. Sara Whittingham thought she would know if something was wrong. But her minor symptoms had a surprising cause.
Australia's leading movement disorder specialists say the chemical regulator has not engaged with their concerns about ...
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has expanded its scientific network in Alzheimer’s and Parkinson’s disease, adding ...
A noninvasive treatment called high-intensity focused ultrasound helped relieve the shaking, stiffness and pain that accompany Parkinson’s disease.
Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in Parkinson's disease in the SLEIPNIR ...
Breakthroughs on Parkinson's could lead to treatments for other brain ills like Lewy body dementia and Alzheimer's.
The age-adjusted Parkinson disease death rate among adults aged 65 years and older declined from 2021 to 2024, according to a ...
With around one million people living with Parkinson’s disease in the U.S. — and 90,000 getting new diagnoses each year — the race is on for a cure. Researchers at Memorial Sloan Kettering Cancer ...
Patients with Gaucher disease type 1 face high age-specific prevalence of Parkinson disease and possible parkinsonian syndrome by age 80 years.
PARKINSON’S disease patients described restored autonomy after STN-DBS, while still fearing symptom recurrence in daily life ...
By Daisy Yuhas This story is part of a series by Public Health Watch and MyRGV.com. Puente News Collaborative is a partner in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results